Document:

Filed by Automated Filing Services Inc. (604) 609-0244 - Response Biomedical Corp. - Exhibit 4.37

CONSULTING AGREEMENT

          This
  Consulting Agreement is effective made as of June 21, 2005 by and between Response
  Biomedical (the “Company”) and #727381 BC Ltd. (the “Consultant”)
  a company wholly owned by Ross MacLachlan. Effective the date of this agreement,
  this Consulting Agreement replaces the Consulting Agreement dated May 2, 2005
  between the Company and Ross MacLachlan which is considered terminated.

	1. 	
      Engagement - The Company hereby agrees to engage
      the services of the Consultant and the Consultant hereby accepts such
      engagement by the Company to perform consulting services for the Company
      on the terms contained herein.

	 	 
	2. 	
      Duties – The Consultant shall, at the request of
      the Company, render management consultations and strategic advise with
      respect to the development of the Company’s business model, the execution
      thereof and matters relating to corporate finance and business
      development. The Consultant will also make himself generally available to
      address other business matters as may be requested by officers of the
      Company from time to time.

	 	 
	3. 	
      Performance – The Consultant agrees not to render
      any services during the term of this Agreement to any company or person
      engaged in a business, which is competitive to the Company.

	 	 
	4. 	
      Terms and Termination - This Agreement shall commence on
      June 21, 2005 for a duration of no less than six months and thereafter
      shall automatically be renewed on a monthly basis, provided, however, that
      after six months either party may terminate this agreement upon 30 days
      written notice delivered to the other party, which termination may be with
      or without cause and for any reason whatsoever.

	 	 
	5. 	
      Compensation –The Consultant shall be compensated
      at a daily rate of $1,500 per day, such that in any given month the daily
      consulting fees will not exceed $4,500 unless authorized by the Company.
      The Consultant shall accrue his time in portions of one quarter days and
      invoice the Company against a monthly retainer of $4,500. The Company
      shall reimburse the Consultant for all reasonable and properly documented
      expenses related to this engagement. Apart from pre approved travel
      arrangements, any expenses in excess of $500 are to be approved in writing
      in advance by an officer of the Company. All compensation payments
      (including retainers) shall include provision for
GST.

		
      The option agreement dated May 2, 2005 granting Ross
      MacLachlan, the owner of the Consultant, 200,000 options at $0.75 remains
      in effect as part of the compensation for the Consultant’s
  services.

	 	 	 
	6. 	
      Confidentiality – The Consultant shall keep in
      confidence and shall not disclose or make available to third parties or
      make any use of any information or documents relating to his/her services
      under this Agreement or to the product, methods of manufacture, trade
      secrets, processes, business or affairs of the Company (other than
      information in the public domain through no fault of the Consultant),
      except with the prior written consent of the Company or to the extent
      necessary in performing tasks assigned to the Consultant by the Company.
      Upon termination of this Agreement, the Consultant will return to the
      Company all documents and other materials related to the services provided
      hereunder or furnished to the Consultant by the Company. The Consultant’s
      obligations under this Section 6 shall survive termination of this
      Agreement.

	 	 	 
	7. 	
      Invention and Discoveries

	 	 	 
		(a) 	
      The Consultant shall promptly disclose and hereby
      transfers and assigns to the Company all right, title and interest to all
      techniques, methods, processes, formulae, improvements, inventions and
      discoveries made or conceived or reduced to practice by the Consultant,
      solely or jointly with others, in the course of providing services
      hereunder or with the use of materials or facilities of the Company during
      the period of this Agreement or which relate to the Company’s business or
      its actual or demonstrably anticipated research or development (except as
      otherwise provided below). When requested by the Company, the Consultant
      will make available to the Company all notes, drawings, data and other
      information relating to the above. The Consultant will promptly sign any
      documents (including U.S. and foreign patent assignments) requested by the
      Company related to the above assignment of rights and inventions and will
      cooperate with the Company at the Company’s request and expense in
      preparation and prosecution of any U.S. or foreign patent applications
      related to such rights and inventions. The obligations under this Section
      7 shall survive termination of this Agreement during the period of
      prosecution of any patent relating to the Project including any reissue,
      reexamination, continuation, continuation-in-part and foreign patents.
      This Agreement does not apply to inventions which were made prior to the
      date of this Agreement.

	 	 	 
		(b) 	
      Any invention, discovery or improvement made or conceived
      by the Consultant which was developed entirely on the Consultant’s own
      time, which does not relate to the Project, the business, research or
      development of the Company or which does not
result

		
       
	
      from any work performed by the Consultant for the
      Company, and which does not involve equipment, supplies, trade secrete
      information or the use of the facilities of the Company shall not be
      subject to this Agreement.

	 	 	 
	8. 	
      Independent Contractor – The Consultant’s
      relationship with the Company shall be that of an independent contractor
      and not that of an employee. The Consultant will not be eligible for any
      employee benefits, nor will the Company make any deductions from the
      Consultant’s fees for taxes, which shall be the Consultant’s
      responsibility. The Consultant shall have no authority to enter into
      contracts that bind the Company or create obligations on the part of the
      Company without the express prior authorization of the Company.

	 	 	 
	9. 	
      Effect of Waiver – The waiver by either party of a
      breach of any provision of this Agreement shall not operate or be
      construed as a waiver of any other provision or any subsequent breach of
      the same provision thereof.

	 	 	 
	10. 	
      Indemnification – Company agrees to indemnify,
      defend and hold harmless Consultant from and against any loss, damage,
      expense and liability that Company may incur as a result of matters
      referenced in Sections 1, 2, and 3.

	 	 	 
	11. 	
      Severability – If any portion of this Agreement is
      held, by a court of competent jurisdiction, to conflict with any Federal,
      state or local law, such portion or portions of this Agreement are hereby
      declared to be of no force and effect in such jurisdiction and this
      Agreement shall otherwise remain in full force and effect and be construed
      as if such portion had not been included herein.

	 	 	 
	12. 	
      Miscellaneous

	 	 	 
		(a) 	
      Section headings are employed in this Agreement for
      reference purposes only and shall not affect the interpretation or meaning
      of this Agreement.

	 	 	 
		(b) 	
      This Agreement shall be governed by and construed in
      accordance with the internal laws of British Columbia.

	 	 	 
		(c) 	
      This Agreement may be signed in counterparts, each of
      which shall be an original and both of which shall constitute one
      instrument.

IN WITNESS WHEREOF, the parties hereto have executed this
Agreement as of the day and year first above written.

	 	Response Biomedical Corp. 
	 	 
	 	 
	 	     /s/ William
      Radvak                                      
      
	 	William Radvak 
	 	 
	 	 
	 	#727381 BC Ltd. 
	 	 
	 	 
	 	      /s/ Ross
      MacLachlan                                    
      
	 	Ross MacLachlanFiled by Automated Filing Services Inc. (604) 609-0244 - Response Biomedical Corp. - Exhibit 4.39

THIS INDEMNITY AGREEMENT made as of the [insert
date],

BETWEEN:

RESPONSE BIOMEDICAL CORP. (the
"Company"), a British Columbia company having an office at 8081 Lougheed
Highway, British Columbia V5A 1W9, and its subsidiaries or affiliates, 

AND:

[insert name] (the “Executive”)
a businessman having a residence at [insert address]

WHEREAS:

	A. 	
      The Executive is a director or officer of the
    Company;

	 	 
	B. 	
      The Company has agreed to provide indemnification to the
      Executive on the terms and conditions contained in this Agreement;
    and,

	 	 
	C. 	
      Notwithstanding the date of its execution and deliver,
      this Agreement shall be conclusively deemed to commence on the day upon
      which the Executive first became or becomes a director or officer of the
      Company and shall continue in effect after the Executive ceases to be a
      director or officer of the Company.

	 	 
		
      NOW THEREFORE in consideration of the Executive
      agreeing to act as a director or officer of the Company, the covenants and
      agreements herein, the payment of $1 made by each party to the other, and
      other good and valuable consideration, the receipt and sufficiency of
      which is acknowledged by each party, the parties agree as
  follows:

	1. 	
      INDEMNIFICATION

	 	 
	1.1 	
      The Company will indemnify the Executive and his heirs,
      executors, administrators and personal representatives (collectively, the
      "Indemnitees") and save the Indemnitees harmless against all liabilities,
      costs, charges and expenses actually and reasonably incurred directly or
      indirectly by the Indemnitees in law, in equity or under any statute or
      regulation in connection with any civil, criminal or administrative claim
      (including without limitation any environmental claim), or any action,
      proceeding or investigation to which the Indemnitees are made a party or
      in which they are otherwise involved as a witness or other participant by
      reason of the Executive having been a director or officer of the Company
      or in respect of any act, matter, deed or thing whatsoever made, done,
      committed, permitted or acquiesced in by the Executive or any failure on
      the part of the Executive to act in or about the execution of his duties
      as a director or officer of the Company, including without limitation any
      and all liabilities arising by breach of any statutory or common law duty
      of care imposed on directors of corporations or
any

breach of any other statutory
provisions or provision of the memorandum and articles of the Company, and
including without limitation any action brought by the Company, if:

	 	(a) 	
      the Executive acted honestly and in good faith with a
      view to the best interests of the Company; and

	 	 	 
	 	(b) 	
      in the case of the criminal or administrative claim,
      action, proceeding or investigation, the Executive had reasonable grounds
      for believing that his conduct was lawful.

	1.2 	
      If the claim, action, proceeding or investigation set out
      in section 1.1 is a claim, action, proceeding or investigation by or on
      behalf of the Company, the Company will, subject to any approvals required
      by law, indemnify the Indemnitees and save the Indemnitees harmless
      against all costs, charges and expenses actually and reasonably incurred
      by the Indemnitees in law, in equity or under any statute or regulation in
      respect of such claim, action, proceeding or investigation provided that
      the Executive fulfils the requirements set forth in subsections 1.1(a) and
      1.1(b) of this Agreement.

	 	 	 
	2. 	
      IDEM

	 	 	 
	2.1 	
      Without limiting the generality of section 1, the costs,
      charges and expenses against which the Company will indemnify the
      Indemnitees include:

	 	 	 
		(a) 	
      any and all fees, costs and expenses actually and
      reasonably incurred by the Indemnitees in investigating, preparing for,
      defending against, providing evidence in, producing documents or taking
      any other action in connection with any commenced or threatened action,
      proceeding or investigation, including reasonable legal fees and
      disbursements, travel and lodging costs;

	 	 	 
		(b) 	
      any amounts reasonably paid in settlement of any action,
      proceeding or investigation;

	 	 	 
		(c) 	
      any amounts paid to satisfy a judgement or penalty,
      including interest and costs; and

	 	 	 
		(d) 	
      all costs, charges and expenses reasonably incurred by
      the Indemnitees in establishing their right to be indemnified pursuant to
      this Agreement.

	3. 	
      TAXABLE BENEFITS

	 	 
	3.1 	
      If the Indemnitees or any of them are required to include
      in their income, or in the income of the estate of the Executive, any
      payment made under this Agreement for the purpose of determining income
      tax payable by the Indemnitees or any of them or the estate of the
      Executive, the Company shall pay an amount by way of indemnity that will
      fully indemnify the Indemnitees or estate of the Executive for the amount
      of all liabilities described in section 1 and section 2 and all income
      taxes payable as a result of the receipt of the indemnity
  payment.

	 	 
	4. 	
      INDEMNIFICATION
NOTICE

	4.1 	
      Upon receipt of a written request by the Indemnitees for
      indemnification under this Agreement (an "Indemnification Notice"), the
      Company will forthwith diligently proceed to obtain such approval and will
      take all other steps necessary to provide the requested indemnification as
      soon as practicable following receipt of the Indemnification
  Notice.

	 	 	 
	5. 	
      NO INVALIDATION

	 	 	 
	5.1 	
      Any failure by the Executive in his capacity as a
      director or officer of the Company or as a director or officer of a
      corporation of which the Company is a shareholder to comply with the
      provisions of the British Columbia Company Act or of the Memorandum and
      Articles of the Company will not invalidate any indemnity to which he is
      entitled under this Agreement.

	 	 	 
	6. 	
      REPRESENTATIONS AND WARRANTIES OF THE
      COMPANY

	 	 	 
	6.1 	
      The Company represents and warrants to the Executive, and
      acknowledges that the Executive is relying on such representations and
      warranties, that:

	 	 	 
		(a) 	
      the Company has the requisite corporate power and
      authority to enter into this Agreement and has taken all necessary steps
      to validly approve the execution and delivery of this Agreement;
  and

	 	 	 
		(b) 	
      this Agreement has been duly executed and delivered by
      the Company and is a valid and binding obligation of the
  Company.

	7. 	
      ACKNOWLEDGEMENTS OF EXECUTIVE

	 	 	 
	7.1 	
      The Executive acknowledges that:

	 	 	 
		(a) 	
      he was represented by counsel of his own choosing in the
      negotiations for and preparation of this Agreement;

	 	 	 
		(b) 	
      he thoroughly discussed all aspects of this Agreement
      with his attorneys;

	 	 	 
		(c) 	
      his attorneys have reviewed this Agreement;

	 	 	 
		(d) 	
      he has carefully read this Agreement and the documents to
      be executed in connection herewith and has had them fully explained by
      counsel, and he is fully aware of the contents and legal effect;
  and

	 	 	 
		(e) 	
      he is freely and voluntarily entering into this Agreement
      on the advice of his respective attorneys.

	8. 	
      ENUREMENT

	 	 
	8.1 	
      This Agreement shall enure to the benefit of the
      Indemnitees and is binding on the

Company and its successors.

	9. 	
      ASSIGNMENT

	 	 
	9.1 	
      A party to this Agreement may not assign his rights under
      this Agreement without the prior written consent of the other party to
      this Agreement.

	 	 
	10. 	
      NUMBER AND GENDER

	 	 
	10.1 	
      Wherever a singular or masculine expression is used in
      this Agreement, that expression is deemed to include the plural, the
      feminine or the body corporate where required by the context.

	 	 
	11. 	
      SEVERABILITY

	 	 
	11.1 	
      If any provision of this Agreement or part thereof is
      found to be illegal or unenforceable, it will be considered separate and
      severable from this Agreement and the remaining provisions of this
      Agreement or parts of the impugned provision will remain in force and be
      binding upon the parties as though the illegal or unenforceable provision
      or part thereof had never been included.

	 	 
	12. 	
      HEADINGS

	 	 
	12.1 	
      The headings in this Agreement are for convenience of
      reference only and do not affect the interpretation of this
    Agreement.

	 	 
	13. 	
      GOVERNING LAW

	 	 
	13.1 	
      This Agreement shall be construed in accordance with the
      laws of the Province of British Columbia.

	 	 
		
      IN WITNESS WHEREOF the parties have executed and
      delivered this Agreement as of the date first above
  written.

RESPONSE BIOMEDICAL CORP.

	________________________________________________	________________________________________________
	Authorized Signatory 	(Executive)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}]]